Omnaris FDA Approval History
FDA Approved: Yes (First approved October 20, 2006)
Brand name: Omnaris
Generic name: ciclesonide
Dosage form: Nasal Spray
Company: Altana Pharma
Treatment for: Allergic Rhinitis
Omnaris (ciclesonide) is an intranasal corticosteroid indicated for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis in patients 12 years of age and older.
Development Timeline for Omnaris
|Oct 20, 2006||Omnaris Altana Pharma - Treatment for Allergic Rhinitis|
|Mar 7, 2006||Altana Submitted New Drug Applications For Ciclesonide Nasal Spray in the U.S. and Canada; Major Milestone in Broadening the Ciclesonide Product Platform|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.